Glutalor Medical Inc. manufactures and markets advanced continuous glucose monitoring (CGM) technology. Our production facility is located in a beautiful corporate park in Exton, PA.
Glucose monitoring is extremely crucial for diabetic patients. However, the traditional finger pricking method is not only painful, inconvenient but also has limited clinical value due to its single point reading. More and more patients including most of Type I patients have transitioned to the new CGM technology due to significant clinical benefits. It has shown that application of CGM technology not only lead a much better treatment regimen from treating doctors and also reduces adverse events due to its trigger and alert functions as a result of continuous monitoring.
Glutalor CGM technology provides shorter, thinner sensors and a smaller transmitter, with the receiver on your own iPhone or Android phones, or smart watches, no need for another receiver. Glutalor’s CGM device still works well-playing sports and even taking shower.